Home › Cardiovascular Disease › Iowa › Des Moines
Cardiovascular Disease clinical trials in Des Moines, IA
5 studies for Cardiovascular Disease are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Iowa Heart Center, West Des Moines · 6 mi away
Product Surveillance Registry
RecruitingObservational study
- West Des Moines, West Des Moines · 6 mi away
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- MercyOne Des Moines Medical Center, Des Moines
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, West Des Moines · 6 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- MercyOne Iowa Heart Center, West Des Moines · 6 mi away
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN19 studies
Other studies in Des Moines
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer10 studies
- Breast Cancer9 studies
- Chronic Lymphocytic Leukemia8 studies
- Colorectal Cancer7 studies
- Overweight6 studies
- Bladder Cancer6 studies
- Obesity5 studies
- Melanoma5 studies
- Acute Myeloid Leukemia5 studies
- Prostate Cancer5 studies
- Multiple Myeloma5 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.